What’s driving the Erdosteine Market Growth? Key Players are Recipharm, Hanmi Pharmaceuticals, Hikma Pharmaceuticals

Increasing use of tobacco-based smoking products coupled with rising cases of respiratory diseases worldwide will drive erdosteine market size in the coming years. Erdosteine is basically a mucolytic medicine that helps in treating symptoms associated with diseases like chronic bronchitis. Indeed, smoking is said to be the key reason for a significant rise in such conditions while other causes including long-term exposure to air pollution, fumes and dust from the environment and repeated cases of acute bronchitis.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3371

Growth drivers

1. North America: Growing trends towards cigarette smoking and exposure to tobacco smoke leading to increase in COPD
2. Europe: Exposure to polluted air quality leading to development of serious medical conditions like bronchitis
3. Asia Pacific: Pharmaceutical market expansion

Environmental issues and other factors also result in both increased mucus production and decreased ability to clear phlegm out. Nevertheless, with erdosteine, patients can easily cough up excess developed mucus owing to the drug’s ability to make congestion less thick and sticky. Rising number of chronic bronchitis cases, primarily due to growing use of tobacco-based smoking products, is anticipated to expand erdosteine market size significantly over the coming years.

Reportedly, the risk of suffering from COPD is high among individuals who start smoking at a very young age, or even to those who are exposed to second-hand smoking. In fact, reports from the U.S. Department of Health & Human Services (HHS) claim that, in 2018, around 4.9 million middle and high school students were using tobacco.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3371

Meanwhile, the Center for Disease Control (CDC) states that in the U.S., each day, about 2,000 youngsters, under the age of 18 years, have their first cigarette, while over 300 under 18 years develop a habit of smoking daily.

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and has imposed a considerable burden on U.S. healthcare sector. As mentioned earlier, smoking is the leading cause of COPD and is remarkably common among Americans. For instance, according to CDC, the country had nearly 38 million cigarettes smokers in the year 2016. Smoking kills more than 480,000 Americans each year and for every person who dies due to smoking related diseases, there are 30 Americans who continue to live with such diseases and be a burden on the country’s healthcare system.

Respiratory diseases have become one of the most significant healthcare and economic burdens across the globe. In the U.S., tobacco smoke is a key contributor to chronic respiratory illnesses, while exposure to air pollutants at workplace and home, viral infections and genetic factors have further contributed as some key factors. Reportedly, with over 600,000 deaths and around six million admissions in hospitals costing over €380 billion each year, respiratory illness is also a significant factor in the European healthcare and pharmaceutical sectors.

In essence, erdosteine, a mucolytic drug which helps in clearing mucus (phlegm) from lungs, is used to treat symptoms pertaining to excessive mucus production triggered by excessive smoking and environment contaminates. With rapid growth in global pharmaceutical and healthcare sectors coupled with rising usage of tobacco-based smoking products, erdosteine market size will exceed USD 150 million by 2025.

Browse key industry insights spread across 180 pages with 148 market data tables and 46 figures & charts from the report, “Erdosteine Market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/erdosteine-market

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com

About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.